Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial of two basal insulin titration algorithms in type 2 diabetes
2014-000493-19Phase 4Terminated
- Sponsor
- Diabeteszentrum Bad Lauterberg im Harz
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine and insulin detemir in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Diabeteszentrum Bad Lauterberg im Harz. Primary endpoint: Time until fasting blood glucose target reached. Started Mar 2014; status: terminated.
02
Drugs
insulin glargineinsulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2014-000493-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000493-19.